Patient Guide: A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 50 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05775289
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 50 locations across the country.

Top locations include:
  • • Detroit, Michigan
  • • Reno, Nevada
  • • Westmead, New South Wales
  • • And 47 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT05775289

How to Join This Clinical Trial - NCTNCT05775289

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-small Cell Lung Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-small Cell Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-small Cell Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05775289 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Detroit, Michigan 48202-2689 - United States

Status: Contact for availability

Clinical Research Site

Reno, Nevada 89502-1576 - United States

Status: Contact for availability

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: Contact for availability

Clinical Research Site

Adelaide, South Australia 5112 - Australia

Status: Contact for availability

Clinical Research Site

Geelong, Victoria 3220 - Australia

Status: Contact for availability

Clinical Research Site

Melbourne, Victoria 3168 - Australia

Status: Contact for availability

Clinical Research Site

Brussel, 1090 - Belgium

Status: Contact for availability

Clinical Research Site

Hasselt, 3500 - Belgium

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Mechelen, 2800 - Belgium

Status: Contact for availability

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non-small Cell Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships